10 transactions in one company, from January 5, 2026 to March 19, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| AN2 Therapeutics, Inc. | ANTX | 10 | — | $9K |
10 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | D | 41,665 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | A | 41,665 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | D | 57,950 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | A | 57,950 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | D | 66,000 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Mar 19 | A | 66,000 | — | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChiefDERIV | Feb 20 | A | 77,000 | $0.00 | —? |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChief | Feb 20 | A | 38,000 | $0.00 | — |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChief | Jan 6 | S | 5,956 | $1.01 | $6K |
| AN2 Therapeutics, Inc. | ANTX | Sanjay ChandaChief | Jan 5 | S | 3,295 | $1.00 | $3K |